Handicare Group AB

Handicare Group is a global provider of mobility solutions in the accessibility and patient handling markets measured by revenue. Co.'s objective is to operate and invest in businesses within the health and rehabilitation sector, own and manage real and personal property and conduct any business compatible therewith.
  • TickerHANDI
  • ISINSE0010298109
  • ExchangeNasdaq Nordic Stockholm
  • SectorHealth Care Equipment & Services
  • CountrySweden
Rickard Anderkrans ...
  • Victor Forssell
  • Viktor Sundberg

Handicare - Feedback from ABGSC Investor Day

Investment highlights provided by CEO and CFO Lift-up programme is well on track The progress is encouraging; EV/EBITA is c.11x ’21e

Rickard Anderkrans ...
  • Victor Forssell
  • Viktor Sundberg

Handicare - Moving on up

Q2 organic decline -32%, adj. EBITA EUR 0.9m ‘20e EBIT up 16% Demand is recovering for Accessibility

Christer Magnergård ...
  • Frank Maaø
  • Håkon Astrup
  • Joachim Gunell
  • Jon Masdal
  • Jørgen Lian
  • Karl-Johan Bonnevier
  • Martin Hoang Nguyen
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolai Farstad Olsen
  • Nicolas McBeath
  • Niklas Wetterling
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Patrik Ling
  • Ragnhild Støer
  • Rune Majlund Dahl
  • Simen Mortensen
  • Stefan Gauffin
  • Tomi Railo

Northern Lights

Rune Majlund Dahl

Handicare (Buy, TP: SEK41.00) - Restructuring benefits now visible

Covid-19 left Q2 revenues just below our estimate, while profitability was ahead. The ‘Lift Up’ restructuring programme is already yielding benefits and tracking ahead of plan, according to the CEO. We are also encouraged by the Accessibility organic growth recovery in June, at c-23%, versus c-40% in April–May. We reiterate our BUY and SEK41 target price.

Rune Majlund Dahl

Handicare (Buy, TP: SEK41.00) - Gradual recovery started in June

Gradual recovery started in June The Q2 top line was below our forecast and organic growth was c-31.6% YOY (we forecast -27.8%), but still with a good activity improvement in June compared to April/May. Accessibility slowed c34.4% organically (we forecast -30%), while Patient Handling saw organic growth slow 30.0% versus our estimate of -26.7%. The adj. EBITA margin of 2.3% beat our estimate of -3.0%, helped by the announced cost-cutting programme.

1 director bought

A director at Handicare Group AB bought 15,000 shares at 39.414SEK and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of...

Rickard Anderkrans ...
  • Victor Forssell
  • Viktor Sundberg

Handicare - Feedback from ABGSC Investor Day

Investment highlights provided by CEO and CFO Lift-up programme is well on track The progress is encouraging; EV/EBITA is c.11x ’21e

Rickard Anderkrans ...
  • Victor Forssell
  • Viktor Sundberg

Handicare - Moving on up

Q2 organic decline -32%, adj. EBITA EUR 0.9m ‘20e EBIT up 16% Demand is recovering for Accessibility

Rune Majlund Dahl

Handicare (Buy, TP: SEK41.00) - Restructuring benefits now visible

Covid-19 left Q2 revenues just below our estimate, while profitability was ahead. The ‘Lift Up’ restructuring programme is already yielding benefits and tracking ahead of plan, according to the CEO. We are also encouraged by the Accessibility organic growth recovery in June, at c-23%, versus c-40% in April–May. We reiterate our BUY and SEK41 target price.

Rune Majlund Dahl

Handicare (Buy, TP: SEK41.00) - Gradual recovery started in June

Gradual recovery started in June The Q2 top line was below our forecast and organic growth was c-31.6% YOY (we forecast -27.8%), but still with a good activity improvement in June compared to April/May. Accessibility slowed c34.4% organically (we forecast -30%), while Patient Handling saw organic growth slow 30.0% versus our estimate of -26.7%. The adj. EBITA margin of 2.3% beat our estimate of -3.0%, helped by the announced cost-cutting programme.

Rickard Anderkrans ...
  • Victor Forssell
  • Viktor Sundberg

Handicare - Messy quarter – but preparing for 2021

Messy quarter; we forecast org. decline of ~31% Lowered group-wide costs lift ‘21e EBIT by 13% Eyes fixed on accelerated growth in ‘21e; EV/EBITA of 10x

Christer Magnergård ...
  • Frank Maaø
  • Håkon Astrup
  • Joachim Gunell
  • Jon Masdal
  • Jørgen Lian
  • Karl-Johan Bonnevier
  • Martin Hoang Nguyen
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolai Farstad Olsen
  • Nicolas McBeath
  • Niklas Wetterling
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Patrik Ling
  • Ragnhild Støer
  • Rune Majlund Dahl
  • Simen Mortensen
  • Stefan Gauffin
  • Tomi Railo

Northern Lights

Christoffer Wang Bjørnsen ...
  • Håkon Astrup
  • Joachim Gunell
  • Jørgen Lian
  • Karl-Johan Bonnevier
  • Martin Arnell
  • Martin Huseby Karlsen
  • Mattias Holmberg
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Patrik Ling
  • Rune Majlund Dahl
  • Tomi Railo

Northern Lights

Ole Martin Westgaard ...
  • Ole-Andreas Krohn
  • Patrik Ling
  • Paul Harper
  • Rune Majlund Dahl

Northern Lights

Alexander Aukner ...
  • Christoffer Wang Bjørnsen
  • Jesper Ingildsen
  • Jimi Lehtonen
  • Joachim Gunell
  • Mattias Holmberg
  • Niclas Gehin
  • Nicolas McBeath
  • Niklas Wetterling
  • Ole Martin Westgaard
  • Ole-Andreas Krohn
  • Olof Larshammar
  • Patrik Ling
  • Rune Majlund Dahl
  • Simen Mortensen
  • Tomi Railo

Northern Lights

Alexander Aukner ...
  • Håkon Astrup
  • Mattias Holmberg
  • Ole-Andreas Krohn
  • Rune Majlund Dahl
  • Viktor Trollsten

Northern Lights

ResearchPool Subscriptions

Get the most out of your insights

Get in touch